Market Overview on Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 is a new market research publication announced by Reportstack. This report provides an overview of Pancreatic Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Pancreatic Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

To access full report with TOC, please visit Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016

Scope

- Extensive coverage of the Pancreatic Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Pancreatic Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Pancreatic Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies Mentioned

A&G Pharmaceutical Inc Abcodia Ltd Acobiom Andraka Technologies, LLC Applied Proteomics Inc Asuragen, Inc. Avant Diagnostics, Inc. BioMarker Strategies LLC Biouniversa srl Cancer Research Technology Ltd Cepheid Cleveland Diagnostics Inc. Clovis Oncology Inc CompanDX Ltd. Courtagen Life Sciences Inc CS-Keys, Inc. Di.V.A.L Toscana srl Exact Sciences Corp German Cancer Research Center GlycoZym Health Discovery Corp Hebrew University of Jerusalem ImmunoCellular Therapeutics Ltd Immunomedics Inc Immunovia AB Imperial College London IV Diagnostics, Inc. John Hopkins University Leitat Technological Center Matrix-Bio, Inc. Mayo Clinic US MDNA Life Sciences Inc Merrimack Pharmaceuticals Inc Metanomics Health GmbH Milagen, Inc. Miraculins Inc Myriad Genetics Inc NanoScale Corporation NatiMab Therapeutics Srl National Cheng-Kung University Hospital Onconome, Inc. OPKO Health Inc Oxford Gene Technology Ltd PeriRx LLC Phenomenome Discoveries Inc Precision Biologics Inc Proplex Technologies Llc Protagen AG Proteome Sciences Plc Queen Mary University of London SDIX LLC Sienna Cancer Diagnostics Ltd SomaLogic Inc Stanford University Temple University Health System Thomas Jefferson University University of Illinois at Chicago University of Pennsylvania US Biomarkers Inc Ventana Medical Systems Inc Viomics Inc. Vitatex Inc. VolitionRX Ltd

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

###